Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
- DOI
- 10.2337/db25-1127
- Published
- 2026 May 1
- Container
- Diabetes
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2337/db25-1127,
title = {Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.},
author = {Sakaki K and Murakami T and Yoshida H and Otani D and Miyake KK and Shimizu Y and Fujimoto H and Yabe D and Nakamoto Y and Inagaki N},
year = {2026},
journal = {Diabetes},
doi = {10.2337/db25-1127},
url = {https://doi.org/10.2337/db25-1127}
}RIS
TY - JOUR TI - Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes. AU - Sakaki K AU - Murakami T AU - Yoshida H AU - Otani D AU - Miyake KK AU - Shimizu Y AU - Fujimoto H AU - Yabe D AU - Nakamoto Y AU - Inagaki N PY - 2026 JO - Diabetes DO - 10.2337/db25-1127 UR - https://doi.org/10.2337/db25-1127 ER -
APA
K, S., T, M., H, Y., D, O., KK, M., Y, S., H, F., D, Y., Y, N., & N, I. (2026). Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.. Diabetes. https://doi.org/10.2337/db25-1127
Source records
- pubmed · retrieved 2026-09-25T02:31:11.728Z